2021
DOI: 10.1016/j.xpro.2021.100755
|View full text |Cite
|
Sign up to set email alerts
|

An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms

Abstract: Sequencing of SARS-CoV-2 genomes is crucial for understanding the genetic epidemiology of the COVID-19 pandemic. It is also critical for understanding the evolution of the virus and also for the rapid development of diagnostic tools. The present protocol is a modification of the Illumina COVIDSeq test. We describe an amplicon-based next-generation sequencing approach with short turnaround time, adapted for bench-top sequencers like MiSeq, iSeq and MiniSeq.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 4 publications
0
17
0
2
Order By: Relevance
“…The Illumina platform is known for its capacity to handle a large number of samples simultaneously by multiplexing samples and for its high yield of sequences [ 17 ]. The MiSeq sequencing technique is usually used to sequence 96 samples in a single flow cell, depending on the different libraries used [ 7 , 18 ]. In the present study, we optimized the protocol to sequence 384 samples in a single flow cell.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Illumina platform is known for its capacity to handle a large number of samples simultaneously by multiplexing samples and for its high yield of sequences [ 17 ]. The MiSeq sequencing technique is usually used to sequence 96 samples in a single flow cell, depending on the different libraries used [ 7 , 18 ]. In the present study, we optimized the protocol to sequence 384 samples in a single flow cell.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, a new protocol for the next-generation sequencing of SARS-CoV-2 RNA using the Illumina MiSeq instrument was described [ 7 ]. Minor modifications were introduced to the Illumina COVIDSeq protocol to sequence 94 SARS-CoV-2-positive samples on a MiSeq instrument.…”
Section: Introductionmentioning
confidence: 99%
“…The authors believed this was probably associated with low genome coverage during sequencing by this sequencer (Román-Reyna et al 2021 ). It may be necessary for the interpretetion the other studies results where sequencing was carried out on different platforms and the data obtained were evaluated in aggregate without taking into account the type of sequencer (e.g., virological studies on COVID-19) (Lu et al 2020 ; Bhoyar et al 2021 ). The above data disclose that the iSeq 100 system may be used to evaluate the bacterial profile of the samples to create an overall picture.…”
Section: Discussionmentioning
confidence: 99%
“…Tambahkan sebanyak 5µl sampel cDNA kedalam well satu dan dua. Seal dan shake dengan kecepatan 1.000x g selama 1 menit kemudian masukan dalam mesin PCR untuk running (Bhoyar et al, 2021).…”
Section: Library Preparationunclassified